Levoxyl
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Recall notice
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
We’re still writing up this recall
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
Source Page by GovInfoNow · govinfonow.com/recall/1927672-pfizer-recalls-levoxyl-levothyroxine-sodium-tablets-usp-tablets-175-mcg · Recall date September 29, 2026 · FDA enforcement record: FDA #D-0052-2027
Cite this page
“Levoxyl.” GovInfoNow, recall dated September 29, 2026. https://govinfonow.com/recall/1927672-pfizer-recalls-levoxyl-levothyroxine-sodium-tablets-usp-tablets-175-mcg. Based on FDA recall #D-0052-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0052-2027%22&limit=1).
How to tell if you have this one
- Brand
Pfizer- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
US Nationwide and Puerto Rico
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0051-2027 | Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10; Lot # 24W07, Exp: 11/30/2026 | 134 1000-count bottles |
| D-0052-2027 | Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.; Lot # 24W06, Exp: 11/30/2026 | 15,815 100-count bottles |
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 29 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0052-2027 (September 29, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0052-2027 to see it in context.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.